Intellectual Property Infringement and Litigation
First written in FY2016. 7 of 24 entries say "Restated". Latest entry: FY2025.
- FY2025RestatedAnnual report
「However, if a third party claims that our group's business activities infringe its intellectual property rights and takes legal action, or if our group takes legal action against a third party, the matter could develop into litigation. Depending on the outcome, our group's business could be enjoined and we could be required to bear financial liabilities such as damages, which could affect our group's operating results and financial position.」
Even after settlement of the specific dispute, the disclosure continues to describe the general risks of future intellectual property litigation, injunctions against business activities and damages claims. - FY2024ReframedAnnual report
「As of the present time, there are no known instances of other companies infringing patents, trademarks, design rights or other intellectual property rights that could affect the business activities of our group. Likewise, there are no known instances of our group's registered intellectual property rights infringing the intellectual property rights of other companies. However, if a third party claims that our group's business activities infringe its intellectual property rights and takes legal action, or if our group takes legal action against a third party, the matter could develop into litigation.」
Following the full settlement in February 2023, the disclosure shifted from specific litigation concerning Rafio to a general description of future intellectual property litigation risks, stating that there are currently no instances of infringement. - FY2023-Q3AchievedAnnual report
「Paramount Bed Co., Ltd. had filed litigation and applied for a provisional injunction against our company, alleging that our products infringed patents held by the company. Following a settlement recommendation by the Intellectual Property High Court, we reached a full settlement on 27 February 2023 to avoid prolonging the dispute, as follows.」
The patent infringement litigation with Paramount Bed Co., Ltd. was fully settled on 27 February 2023, resolving the dispute. The settlement provided for payment of ¥153 million, including late-payment damages, compared with the first-instance judgment's payment order of ¥381,222,226 plus other amounts. - FY2023-Q2Additional recognition of late-payment damages in the provision for litigation lossesAnnual report
「In addition, the company recognized ¥49 million in equity-method investment income, up 76.6% year on year, as non-operating income, and ¥27 million in foreign exchange losses and ¥71 million in valuation losses on derivatives as non-operating expenses. As an extraordinary loss, it also recognized ¥9 million in additional provision for litigation losses for late-payment damages arising from the judgment described in the notice concerning the recognition of extraordinary losses published on 8 October 2020.」
Regarding the litigation with Paramount Bed, the company additionally recognized ¥9 million in provision for litigation losses for late-payment damages. - FY2023-Q1Additional recognition of late-payment damages in the provision for litigation lossesAnnual report
「In addition, the company recognized ¥10 million in equity-method investment income, down 55.0% year on year, and ¥49 million in foreign exchange gains, up 451.4% year on year, as non-operating income. As an extraordinary loss, it also recognized ¥4 million in additional provision for litigation losses for late-payment damages arising from the judgment described in the notice concerning the recognition of extraordinary losses published on 8 October 2020.」
Regarding the litigation with Paramount Bed, the company additionally recognized ¥4 million in provision for litigation losses for late-payment damages. The provision balance was ¥530.008 million. - FY2022Additional recognition of a provision for litigation lossesAnnual report
「In addition, the company recognized ¥69 million in equity-method investment income, down 46.3% year on year, ¥186 million in foreign exchange gains, up 753.8% year on year, and ¥31 million in insurance surrender value as non-operating income. As an extraordinary loss, it also recognized ¥19 million in additional provision for litigation losses for late-payment damages arising from the judgment described in the notice concerning the recognition of extraordinary losses published on 8 October 2020.」
The company additionally recognized ¥19 million in late-payment damages related to the litigation with Paramount Bed, bringing the provision for litigation losses to ¥525.203 million. - FY2022-Q3Additional recognition of late-payment damages in the provision for litigation lossesAnnual report
「In addition, the company recognized ¥40 million in equity-method investment income, down 62.5% year on year, ¥88 million in foreign exchange gains, up 281.3% year on year, and ¥31 million in insurance surrender value as non-operating income. As an extraordinary loss, it also recognized ¥14 million in additional provision for litigation losses for late-payment damages arising from the judgment described in the notice concerning the recognition of extraordinary losses published on 8 October 2020.」
The company additionally recognized ¥14 million in late-payment damages related to the first-instance judgment, bringing the provision for litigation losses on the balance sheet to ¥520.451 million. - FY2022-Q2Additional recognition of late-payment damages in the provision for litigation lossesAnnual report
「In addition, the company recognized ¥27 million in equity-method investment income, down 60.3% year on year, and ¥31 million in insurance surrender value as non-operating income. As an extraordinary loss, it also recognized ¥9 million in additional provision for litigation losses for late-payment damages arising from the judgment described in the notice concerning the recognition of extraordinary losses published on 8 October 2020.」
For litigation losses related to the first-instance judgment, the company additionally recognized ¥9 million in late-payment damages, bringing the provision for litigation losses to ¥515.751 million. - FY2022-Q1Additional recognition of late-payment damages in the provision for litigation lossesAnnual report
「In addition, the company recognized ¥22 million in equity-method investment income, up 2.7% year on year, and ¥31 million in insurance surrender value as non-operating income. As an extraordinary loss, it also recognized ¥4 million in additional provision for litigation losses for late-payment damages arising from the judgment described in the notice concerning the recognition of extraordinary losses published on 8 October 2020.」
For litigation losses related to the first-instance judgment, the company additionally recognized ¥4 million in late-payment damages, bringing the provision for litigation losses on the balance sheet to ¥510.946 million. - FY2021Recognition of a ¥506 million provision for litigation losses based on the first-instance judgment and continuation of the appealAnnual report
「As we disagreed with the portion of the first-instance judgment that partially upheld Paramount Bed Co., Ltd.'s claims, we decided to appeal, as stated in the notice dated 1 October 2020 concerning the filing of the litigation. However, in preparation for the possibility that the judgment ultimately becomes final in accordance with the Tokyo District Court's judgment, we recognized ¥506.142 million as an additional provision for litigation losses, recorded as an extraordinary loss, for the claims and late-payment damages arising from the judgment.」
The first-instance judgment ordered payment of ¥381.222 million plus late-payment damages. The company continued its appeal while recognizing a ¥506.142 million provision for litigation losses in preparation for the judgment becoming final. - FY2021-Q3Recognition of a ¥501 million provision for litigation losses and continuation of the appealAnnual report
「As we disagreed with the portion of the first-instance judgment that partially upheld Paramount Bed Co., Ltd.'s claims, we decided to appeal, as stated in the notice dated 1 October 2020 concerning the filing of the litigation. However, in preparation for the possibility that the judgment ultimately becomes final in accordance with the Tokyo District Court's judgment, we recognized ¥501 million as an additional provision for litigation losses, recorded as an extraordinary loss, for the claims and late-payment damages arising from the judgment.」
The company continued its appeal against the first-instance judgment while recognizing ¥501 million as an additional provision for litigation losses in preparation for the judgment becoming final. - FY2021-Q2Recognition of a ¥491 million provision for litigation losses following the judgment and continuation of the appealAnnual report
「As we disagreed with the portion of the first-instance judgment that partially upheld Paramount Bed Co., Ltd.'s claims, we decided to appeal, as stated in the notice dated 1 October 2020 concerning the filing of the litigation. However, in preparation for the possibility that the judgment ultimately becomes final in accordance with the Tokyo District Court's judgment, we recognized ¥496 million as an additional provision for litigation losses, recorded as an extraordinary loss, for the claims and late-payment damages arising from the judgment.」
The company continued its appeal against the first-instance judgment while recognizing a ¥496 million provision for litigation losses in preparation for the judgment becoming final. - FY2021-Q1MaterialisedAnnual report
「As stated in the notice dated 25 September 2020 concerning the judgment in the litigation against our company, the Tokyo District Court issued a judgment against our company in the litigation brought by Paramount Bed Co., Ltd., partially upholding Paramount Bed Co., Ltd.'s claims and ordering us to pay ¥381 million plus late-payment damages (the "first-instance judgment").」
In the patent infringement litigation concerning Rafio and other products, the Tokyo District Court issued a first-instance judgment partially upholding the claims. The company appealed and recognized a provision for litigation losses of ¥491 million in preparation for the judgment becoming final. - FY2020WorsenedAnnual report
「Subsequently, on 18 June 2020, a motion to amend the claim was filed, changing the damages claimed to ¥1,209.931 million.」
In the ongoing patent infringement litigation concerning Rafio and other products, the damages claimed changed from ¥550 million to ¥1,209.931 million. - FY2019MitigatedAnnual report
「The company had filed with the Tokyo District Court on 26 October 2018 an application for a provisional injunction against our company concerning the suspension of sales, offers for sale or importation of our Rafio product, among other matters, but withdrew the application on 12 July 2019.」
The patent infringement litigation concerning Rafio and other products remains pending, but the application for a provisional injunction against sales and other activities was withdrawn on 12 July 2019. - FY2019-Q3RestatedAnnual report
「The Company has been sued by パラマウントベッド株式会社 in the Tokyo District Court, as of 19 July 2017, for allegedly infringing 3 patents held by the company with the Company's product "Rafio." The claims seek an injunction against the sale, offer for sale or importation of "Rafio," disposal of "Rafio," and damages of ¥550 million. In addition, the company filed an application with the Tokyo District Court, as of 26 October 2018, for provisional measures concerning an injunction against the sale, offer for sale or importation of the Company's product "Rafio."」
Patent infringement litigation concerning Rafio and an application for a provisional injunction against sales and other activities remain pending. The company has indicated its intention to contest the litigation and believes that it can continue sales even if the provisional injunction is granted. - FY2019-Q2RestatedAnnual report
「The Company has been sued by パラマウントベッド株式会社 in the Tokyo District Court, as of 19 July 2017, for allegedly infringing 3 patents held by the company with the Company's product "Rafio." The claims seek an injunction against the sale, offer for sale or importation of "Rafio," disposal of "Rafio," and damages of ¥550 million. In addition, the company filed an application with the Tokyo District Court, as of 26 October 2018, for provisional measures concerning an injunction against the sale, offer for sale or importation of the Company's product "Rafio."」
Patent infringement litigation concerning Rafio and an application for a provisional injunction against sales and other activities remain pending. - FY2019-Q1WorsenedAnnual report
「In connection with the lawsuit filed by パラマウントベッド株式会社, which is described in the notes on contingent liabilities, the company filed an application with the Tokyo District Court, as of 26 October 2018, for provisional measures concerning an injunction against the sale, offer for sale or importation of the Company's product "Rafio."」
In connection with the ongoing patent infringement lawsuit concerning Rafio, a new application was filed for provisional measures seeking an injunction against its sale and related activities. - FY2018RestatedAnnual report
「The Company has been sued by パラマウントベッド株式会社 in the Tokyo District Court, as of 19 July 2017, for allegedly infringing 3 patents held by the company with the Company's product "Rafio." The claims seek an injunction against the sale, offer for sale or importation of "Rafio," disposal of "Rafio," and damages of ¥550 million.」
The patent infringement lawsuit concerning Rafio remains ongoing, including claims for an injunction, disposal and ¥550 million in damages. - FY2018-Q3RestatedAnnual report
「The Company has been sued by パラマウントベッド株式会社 in the Tokyo District Court, as of 19 July 2017, for allegedly infringing 3 patents held by the company with the Company's product "Rafio." The claims seek an injunction against the sale, offer for sale or importation of "Rafio," disposal of "Rafio," and damages of ¥550 million.」
The patent infringement lawsuit concerning Rafio remains ongoing, and the claims for an injunction, disposal and ¥550 million in damages continue to be disclosed. - FY2018-Q2RestatedAnnual report
「The Company has been sued by パラマウントベッド株式会社 in the Tokyo District Court, as of 19 July 2017, for allegedly infringing 3 patents held by the company with the Company's product "Rafio." The claims seek an injunction against the sale, offer for sale or importation of "Rafio," disposal of "Rafio," and damages of ¥550 million.」
The patent infringement lawsuit concerning Rafio remains ongoing, and the claims and the ¥550 million damages claim continue to be disclosed. - FY2018-Q1RestatedAnnual report
「The Company has been sued by パラマウントベッド株式会社 in the Tokyo District Court, as of 19 July 2017, for allegedly infringing 3 patents held by the company with the Company's product "Rafio." The claims seek an injunction against the sale, offer for sale or importation of "Rafio," disposal of "Rafio," and damages of ¥550 million. The Company believes that its products do not infringe any of the patents or that grounds exist for invalidating the company's patents, and intends to contest the company's claims in the litigation.」
The patent infringement lawsuit concerning Rafio and the Company's policy of contesting the company's claims continue to be disclosed. The impact of the litigation is considered difficult to predict at this time. - FY2017MaterialisedAnnual report
「パラマウントベッド株式会社 filed a lawsuit alleging that the Company's product "Rafio" infringes 3 patents held by the company, seeking an injunction against the sale, offer for sale or importation of "Rafio," an order to dispose of "Rafio," and damages. The amount claimed is ¥550 million plus delay damages.」
The intellectual property risk previously disclosed as a possibility of future litigation materialized as an actual patent infringement lawsuit concerning Rafio. - FY2016First statedAnnual report
「However, if a third party claims that the Group has infringed intellectual property rights in connection with its business activities and takes legal action, or if the Group takes legal action itself, the matter could develop into litigation.」
At the time, the Company stated that there was no infringement affecting business activities, while disclosing the risk of future litigation.